Source
32 articles citing this source
Sunday raised $165 million at a $1.15 billion valuation to deploy its household robot Memo to homes by Thanksgiving 2026, using a novel low-cost data capture approach.
BYD has launched its second-generation Blade Battery and a 1,500 kW FLASH Charging network that can take a compatible EV from 10 to 97 percent in nine minutes, with plans to deploy 20,000 stations across China by year-end and begin overseas rollout.
Petrelintide met its primary endpoint with placebo-like tolerability, but a dose ceiling and a seven-point efficacy gap to Lilly's eloralintide raise questions about its standalone future.
The FDA rejected uniQure's Phase I/II data for AMT-130 and now demands a sham surgery-controlled Phase 3 trial, reversing its own prior guidance and sending shares down 40 percent.
Beam Therapeutics' BEAM-302 has achieved the first-ever in-vivo base editing correction of a disease-causing mutation in human patients, reaching therapeutic AAT levels in a Phase 1/2 trial for alpha-1 antitrypsin deficiency. A pivotal Q1 2026 data readout is now imminent.
2026 marks the transition from noisy quantum experiments to error-corrected commercial systems, with neutral atom platforms from QuEra, Atom Computing, and Pasqal leading the charge.
CoreWeave reports record Q4 revenue but a $452 million loss, while approximately $21 billion in total debt and securities class actions test the viability of GPU-backed financing.
Aviation automation startup Skyryse raises $300M Series C at $1.15B valuation to certify SkyOS, a fly-by-wire system replacing complex mechanical controls with a single joystick and touchscreens.